Loading...
OTC Markets
Totals
Securities
12,236
Dollar Vol
$2.6B
Share Vol
3.2B
Trades
327,254

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

BSX
Boston Scientific Corp.

Common Stock

106.21

-1.55

-1.44%

Delayed (15 Min) Trade Data: 04:10pm 07/24/2025
Filings and Disclosure
OTC Disclosure & News Service
Active
Inactive
All

The company has not provided financial reports or other disclosures to OTC Markets Group.

SEC Filings
Form Type
Form Type
Received
Received
Period End Date
Period End Date
Report
Report
8-K07/23/202507/23/2025PDFRTFHTMLXLS
407/02/202507/01/2025PDFRTFHTMLXLS
407/02/202507/01/2025PDFRTFHTMLXLS
407/02/202507/01/2025PDFRTFHTMLXLS
14407/01/2025PDFRTFHTML
306/30/202506/30/2025PDFRTFHTMLXLS
11-K06/18/202512/31/2024PDFRTFHTMLXLS
406/04/202506/04/2025PDFRTFHTMLXLS
14406/04/2025PDFRTFHTML
406/03/202506/02/2025PDFRTFHTMLXLS
More
Displaying 10 of 4712 Filings
Insider Disclosure
OTC Disclosure & News

No insider disclosure available for BSX.

SEC Transactions Last 6 Months
Buy / Sell
Buys
16
Sells
86
Total
102
Shares
Bought
282,351
Sold
1,050,069
Gross
1,332,420
Net
-767,718
SEC Transactions Last 2 Years
NYSE
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.